PremiumRatingsActinium Pharmaceuticals: Promising Pipeline and Strategic Partnerships Drive Buy Rating Actinium Pharmaceuticals: Strong Buy Rating Driven by Promising Pipeline and Stable Financial Position Actinium Pharmaceuticals: Innovative Clinical Trials and Promising Preclinical Data Drive Buy Rating PremiumThe FlyActinium’s Actimab-A shows antileukemic activity in AML models Levi & Korsinsky LLP Notifies Shareholders of Actinium Pharmaceuticals, Inc.(ATNM) of a Class Action Lawsuit and an Upcoming Deadline Actinium Pharmaceuticals: Strong Financial Health and Promising Clinical Progress Drive Buy Rating PremiumThe FlyActinium Pharmaceuticals enters supply pact with Eckert & Ziegler Actinium Pharmaceuticals: Promising Clinical Advancements and Strong Financial Outlook Support Buy Rating Actinium Pharma enters research collaboration with Memorial Sloan Kettering 
